Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact

Review Series

Angiogenesis

Series edited by David Cheresh

Therapeutic manipulation of angiogenesis would be desirable for the treatment of a variety of diseases, including cancer and heart disease. This short series focuses this therapeutic potential and specifically on integrins and matrix metalloproteinases as potential targets.

Articles in series

The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development
Brian P. Eliceiri, David A. Cheresh
Brian P. Eliceiri, David A. Cheresh
Published May 1, 1999
Citation Information: J Clin Invest. 1999;103(9):1227-1230. https://doi.org/10.1172/JCI6869.
View: Text | PDF

The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development

  • Text
  • PDF
Abstract

Authors

Brian P. Eliceiri, David A. Cheresh

×

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization
Jeffrey M. Isner, Takayuki Asahara
Jeffrey M. Isner, Takayuki Asahara
Published May 1, 1999
Citation Information: J Clin Invest. 1999;103(9):1231-1236. https://doi.org/10.1172/JCI6889.
View: Text | PDF

Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization

  • Text
  • PDF
Abstract

Authors

Jeffrey M. Isner, Takayuki Asahara

×

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention
William G. Stetler-Stevenson
William G. Stetler-Stevenson
Published May 1, 1999
Citation Information: J Clin Invest. 1999;103(9):1237-1241. https://doi.org/10.1172/JCI6870.
View: Text | PDF

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention

  • Text
  • PDF
Abstract

Authors

William G. Stetler-Stevenson

×

Advertisement

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts